Positive data from five clinical trials and new treatment guidelines for mechanical thrombectomy devices have ushered in a new era in stroke care. Medtech Insight sat down with Brett Wall, Vice President and President of Medtronic Neurovascular at the recent SNIS meeting, to find out what impact the trials and guidelines are having on stroke care, the market for mechanical thrombectomy devices, demand for Solitaire FR, and the company's plans for innovation. Read more at: https://www.pharmamedtechbi.com/a/2015700099